To prove that CFH is the target of GT103 in EVs, we probed a western blot of EVs purified from the conditioned media from the CMT167 murine lung cancer cell line and two CFH CRISPR/Cas9 knockout derivatives. The gene discussed is CFH; the disease is lung carcinoma.